Publication | Closed Access

Population Pharmacokinetics/Pharmacodynamics of Erlotinib and Pharmacogenomic Analysis of Plasma and Cerebrospinal Fluid Drug Concentrations in Japanese Patients with Non-Small Cell Lung Cancer

Pharmacogenomic AnalysisMedicinePopulation Pharmacokinetics/pharmacodynamicsPharmacologyBronchial NeoplasmPharmacotherapyAnti-cancer AgentLung CancerOncologyRadiation OncologyTumor MicroenvironmentPharmacokineticsJapanese Patients